Open AccessAcute eosinophilic pneumonia accompanied with COVID ‐19: a case report
Author(s) -
Murao Koutaro,
Saito Atsushi,
Kuronuma Koji,
Fujiya Yoshihiro,
Takahashi Satoshi,
Chiba Hirofumi
Publication year - 2020
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.683
Subject(s) - medicine , chest radiograph , pneumonia , eosinophilic pneumonia , prednisolone , covid-19 , chest pain , respiratory failure , eosinophil , asthma , gastroenterology , disease , respiratory disease , infectious disease (medical specialty) , lung
We report a case of acute eosinophilic pneumonia (AEP) triggered by coronavirus disease 2019 (COVID‐19) infection. A 77‐year‐old man experienced left‐sided chest pain and shortness of breath. Reverse transcription‐polymerase chain reaction (RT‐PCR) for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) revealed a positive result, and he was treated with favipiravir, ciclesonide, and lascufloxacin, but he showed poor improvement. On the other hand, computed tomography (CT) images were atypical for COVID‐19 infection, and the elevation of eosinophil was found in blood and the fluid obtained by bronchoscopy. So, we clinically diagnosed this case as AEP. Administration of prednisolone dramatically improved the patient's clinical condition and chest radiograph findings, which were consistent with the clinical course of AEP. This case suggests the importance of considering the complications of AEP when treating patients with COVID‐19 infection.